Connect
MJA
MJA

Pharmaceutical preparations

Research

The impact of tightened prescribing restrictions for PBS-subsidised opioid medicines and the introduction of half-pack sizes, Australia, 2020–21: an interrupted time series analysis

Forrest C Koch, Jake Olivier, Jonathan Brett, Nicholas A Buckley, Natasa Gisev, Sallie Pearson and Benjamin Daniels

Med J Aust 2024; 220 (6): 315-322 Free

Research letters

The uptake of long‐acting depot buprenorphine for treating opioid dependence in Australia, 2019–2022: longitudinal sales data analysis

Nicholas Lintzeris, Victoria Hayes and Adrian J Dunlop

Med J Aust 2024; 220 (6): 339-340 Free

Editorials

Interventions for reducing the prescribing of pharmaceutical opioids in Australia: are they effectively reducing opioid harm?

Suzanne Nielsen and Ting Xia

Med J Aust 2024; 220 (6): 311-312

Medical education / Lessons from practice

Hidden danger: maize starch excipient allergy

Lipin Lukose, Shrey Seth, Kamal Sud, Brian Nankivell, Mary Ann Nicdao and Ronald L Castelino

Med J Aust 2024; 220 (4): 184-185 Free

Editorial

Antibiotics or watchful waiting for acute otitis media in urban Aboriginal and Torres Strait Islander children?

Valerie M Swift and Christopher G Brennan‐Jones

Med J Aust 2024; 220 (4): 186-187 Free

Research

The views of parents and carers on managing acute otitis media in urban Aboriginal and Torres Strait Islander children: a qualitative study

Jennifer S Reath, Sarah O'Brien, Letitia Campbell, Hasantha Gunasekera, Claudette A Tyson, Deborah A Askew, Wendy Hu, Tim Usherwood, Kelvin Kong, Peter Morris, Amanda J Leach, Robyn Walsh and Penelope A Abbott

Med J Aust 2024; 220 (4): 202-207 Free

Perspectives

Inflammation: the next target for secondary prevention in coronary artery disease

Samia Kazi, James J H Chong and Clara K Chow

Med J Aust 2024; 220 (3): 115-120 Free

Letters

Proposals to waive intellectual property rights for pandemic response products in the World Health Organization pandemic accord need Australia's support

Thomas Cueni and Elizabeth Somer

Med J Aust 2023; 219 (9): 439-439 Free

Letters

Proposals to waive intellectual property rights for pandemic response products in the World Health Organization pandemic accord need Australia's support

Deborah Gleeson, James Scheibner and Dianne Nicol

Med J Aust 2023; 219 (9): 439-439 Free

Perspectives

Sodium glucose cotransporter 2 inhibitor‐induced ketoacidosis is unlikely in patients without diabetes

Lisa M Raven, Christopher A Muir and Jerry R Greenfield

Med J Aust 2023; 219 (7): 293-294 Free

Perspectives

The rise of direct‐to‐consumer telemedicine services in Australia: implications for primary care and future research

Darran Foo, Samantha Spanos, Genevieve Dammery, Louise A Ellis, Simon M Willcock and Jeffrey Braithwaite

Med J Aust 2023; 219 (8): 344-347 Free

Letters

Avoiding severe drug hypersensitivity reactions: a case for HLA genotyping for at‐risk patients

Helen Y Sun, Yaron Gu and Deshan F Sebaratnam

Med J Aust 2023; 219 (6): 285-285

Medical education / Lessons from practice

The not‐so‐natural herb: a case of exogenous Cushing syndrome

Yi‐An Pan, David Roberts, Yi‐An Pan and David Roberts

Med J Aust 2023; 219 (7): 297-298

Letters

Increased prescribing of psychotropic medication for children and adolescents during the COVID‐19 pandemic: no cause for alarm

Alain Braillon and Wendy A Rogers

Med J Aust 2023; 219 (6): 285-285

Perspectives

Carbapenemase‐producing Enterobacterales: a profound threat to Australian public health

Erin Flynn, Lito E Papanicolas, Nicholas Anagnostou, Morgyn S Warner, Geraint B Rogers, Erin Flynn, Lito E Papanicolas, Nicholas Anagnostou, Morgyn S Warner and Geraint B Rogers

Med J Aust 2023; 219 (7): 290-292 Free

Study protocol

Activating pharmacists to reduce the frequency of medication‐related problems (ACTMed): a stepped wedge cluster randomised trial

Jean Spinks, Richard Violette, Douglas IR Boyle, Dennis Petrie, Laura Fanning, Kerry K Hall, Fiona Kelly, Amanda J Wheeler, Robert S Ware, Joshua Byrnes, Esa Chen, Andrew Donald, Nicolette Ellis, Megan DelDot, Lisa Nissen, Jean Spinks, Richard Violette, Douglas IR Boyle, Dennis Petrie, Laura Fanning, Kerry K Hall, Fiona Kelly, Amanda J Wheeler, Robert S Ware, Joshua Byrnes, Esa Chen, Andrew Donald, Nicolette Ellis, Megan DelDot and Lisa Nissen

Med J Aust 2023; 219 (7): 325-331 Free

Letters

Current and emerging medications for the management of obesity in adults

Joshua M Inglis, Ganessan Kichenadasse and Arduino A Mangoni

Med J Aust 2023; 219 (4): 187-187

Letters

Current and emerging medications for the management of obesity in adults

Rosalind Walmsley and Priya Sumithran

Med J Aust 2023; 219 (4): 188-188

Research

The effectiveness of vaccination for preventing hospitalisation with COVID‐19 in regional Queensland: a data linkage study

Nicolas R Smoll, Mahmudul Hassan Al Imam, Connie Shulz, Robert Booy and Gulam Khandaker

Med J Aust 2023; 219 (4): 162-165 Free

Narrative review

Current approaches in the recognition and management of eating disorders

Phillipa J Hay, Rebekah Rankin, Lucie Ramjan and Janet Conti

Med J Aust 2023; 219 (3): 127-134 Free

Guideline summary

Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations

Aili V Langford, Christine CW Lin, Lisa Bero, Fiona M Blyth, Jason Doctor, Simon Holliday, Yun‐Hee Jeon, Joanna Moullin, Bridin Murnion, Suzanne Nielsen, Rawa Osman, Jonathan Penm, Emily Reeve, Sharon Reid, Janet Wale, Carl R Schneider* and Danijela Gnjidic*

Med J Aust 2023; 219 (2): 80-89 Free

Research

Psychotropic and other medicine use at time of death by suicide: a population‐level analysis of linked dispensing and forensic toxicology data

Kate M Chitty, Nicholas A Buckley, Jessy Lim, Zein Ali, Jennifer L Schumann, Rose Cairns, Benjamin Daniels, Sallie A Pearson, David B Preen and Andrea L Schaffer

Med J Aust 2023; 219 (2): 63-69 Free

Perspectives

Proposals to waive intellectual property rights for pandemic response products in the World Health Organization pandemic accord need Australia's support

Deborah Gleeson, James Scheibner and Dianne Nicol

Med J Aust 2023; 219 (2): 46-48 Free

Research

Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID‐19 pandemic, 2013–2021: a retrospective cohort study

Stephen J Wood, Jenni Ilomäki, Jacqueline Gould, George SQ Tan, Melissa Raven, Jon N Jureidini and Luke E Grzeskowiak

Med J Aust 2023; 219 (1): 18-25 Free

Editorial

Increased prescribing of psychotropic medication for children and adolescents during the COVID‐19 pandemic: no cause for alarm

Philip L Hazell

Med J Aust 2023; 219 (1): 16-17 Free